OPKO Health Announces Leadership Changes at BioReference Laboratories

- January 26th, 2018

OPKO Health (NASDAQ:OPK), announces that Gregory Henderson, M.D., Ph.D., has resigned from his position as President of BioReference Laboratories, an OPKO Health company and the third largest commercial laboratory in the United States, effective immediately. As quoted in the press release: “We thank Dr. Henderson for his work at BioReference Laboratories and wish him continued success … Continued

OPKO Health (NASDAQ:OPK), announces that Gregory Henderson, M.D., Ph.D., has resigned from his position as President of BioReference Laboratories, an OPKO Health company and the third largest commercial laboratory in the United States, effective immediately.
As quoted in the press release:

“We thank Dr. Henderson for his work at BioReference Laboratories and wish him continued success in his endeavors,” said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO Health.  “The Company seeks to appoint an executive with the leadership skills and industry expertise consistent with OPKO’s vision for expanding BioReference’s role in the rapidly evolving diagnostic business.”

Click here to read the full press release.

Is the biotech market the perfect mesh between the technology and pharmaceutical market?

 
Read our FREE outlook report below!
 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply